In order to detect a medium effect size of 0.625 (average accuracy increase of 0.08 and standard deviation of 0.128) for the primary outcome (MIFT accuracy), with an intra subject correlation of 0.3, a power of 80% a false positive rate set to 5%, and assuming a 30% dropout rate, the target sample size was 44 participants
You're interested in TRT for all the right reasons: better performance, more energy, improved body composition
By week 4, the scale had moved again
PMID: 29432718
Typical Cycle Lengths Mild to moderate injury (tendon, ligament, muscle): 24 weeks at 250500mcg per day Severe or post-operative injuries: 46 weeks, sometimes extending to 8 weeks Gastrointestinal issues (ulcers, IBS): 46 weeks at 250500mcg per day, oral or subQ Neurological repair or systemic inflammation: 46 weeks, systemic dosing recommended For most users, results begin to show within the first 710 days , especially in soft tissue or gut repair cases
Patients with conditions like chronic fatigue syndrome or fibromyalgia might be interested in exploring the use of glutathione in their management plans, in conjunction with their healthcare provider's guidance It is important, however, for both patients and prescribers to note that while there is anecdotal and initial scientific support for these uses, the established evidence is limited, and further research is required to fully understand the efficacy and safety of glutathione in these contexts
